Extracellular adenosine metabolism in immune cells in melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1073, doi. 10.1007/s00262-014-1553-8
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 10
Results: 12
1
2
Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival-a substudy of the MIMOSA trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1037, doi. 10.1007/s00262-014-1569-0
- By:
- Publication type:
- Article
3
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1023, doi. 10.1007/s00262-014-1571-6
- By:
- Publication type:
- Article
4
A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 999, doi. 10.1007/s00262-014-1572-5
- By:
- Publication type:
- Article
5
Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1009, doi. 10.1007/s00262-014-1573-4
- By:
- Publication type:
- Article
6
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1047, doi. 10.1007/s00262-014-1574-3
- By:
- Publication type:
- Article
7
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1061, doi. 10.1007/s00262-014-1575-2
- By:
- Publication type:
- Article
8
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1081, doi. 10.1007/s00262-014-1580-5
- By:
- Publication type:
- Article
9
Shaping of an effective immune microenvironment to and by cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 991, doi. 10.1007/s00262-014-1590-3
- By:
- Publication type:
- Article
10
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1093, doi. 10.1007/s00262-014-1600-5
- By:
- Publication type:
- Article
11
Erratum to: Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.
- Published in:
- 2014
- By:
- Publication type:
- Erratum